Authors: Föger-Samwald, Ursula
Dovjak, Peter
Azizi-Semrad, Ursula
Kerschan-Schindl, Katharina
Pietschmann, Peter
Title: Osteoporosis
Other Titles: pathophysiology and therapeutic options
Language (ISO): en
Abstract: Osteoporosis is a metabolic bone disease that, on a cellular level, results from osteoclastic bone resorption not compensated by osteoblastic bone formation. This causes bones to become weak and fragile, thus increasing the risk of fractures. Traditional pathophysiological concepts of osteoporosis focused on endocrine mechanisms such as estrogen or vitamin D deficiency as well as secondary hyperparathyroidism. However, research over the last decades provided exiting new insights into mechanisms contributing to the onset of osteoporosis, which go far beyond this. Selected mechanisms such as interactions between bone and the immune system, the gut microbiome, and cellular senescence are reviewed in this article. Furthermore, an overview on currently available osteoporosis medications including antiresorptive and bone forming drugs is provided and an outlook on potential future treatment options is given.
Subject Headings: Osteoporosis
Gut microbiome
Osteoporosis treatment
Publishers Link:
Issue Date: 2020-07-20
Rights link:
Provenance: IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund
Citation: Föger-Samwald, U., Dovjak, P., Azizi-Semrad, U., Kerschan-Schindl, K., & Pietschmann, P. (2020). Osteoporosis: Pathophysiology and therapeutic options. EXCLI Journal, 19, 1017-1037.
Appears in Collections:Review Articles 2020

Files in This Item:
File Description SizeFormat 
excli2020-2591.pdfDNB1.1 MBAdobe PDFView/Open

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons